Ulrike Köhl, MD PhD Hannover Medical School

Dr. Köhl is professor and director of the Institute of Cellular Therapeutics at Medical School Hannover (MHH). She studied both, Biology and Medicine, received her PhD in 1995 and continued her scientific work at the MD Anderson Cancer Centre in Houston, USA.

In 2000, she became the head of the laboratory of stem cell transplantation and immunotherapy in the Paediatric Haematology and Oncology at the University Hospital, Frankfurt, Germany.

Since May 2012, she started with a full professorship for Stem Cell Transplantation and Cellular Therapeutics in the Integrated Research and Treatment Centre for Transplantation (IFB-Tx), leading the GMP Development Unit (GMPDU) and the Cellular Therapy Centre (CTC), being one of the Qualified Persons in the latter one.

All her goals have a clinical focus on the development and manufacturing of cell-based therapies including Advanced Therapy Medicinal Products (ATMPs) and the improvement of cell processing strategies. She has a specific focus on primary human NK cells including chimeric antigen receptors (CAR) expressing NK cells. She is a member of numerous national and international societies and is serving as a reviewer for the European Medicine Agency.